Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Everett Meyer

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 22, 2020
Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel AgentsChristopher Lemieux, Laura J Johnston, Robert Lowsky, et al.
Transplantation and Cellular Therapy|May 14, 2026
Chimeric Antigen Receptor T-Cell Therapy in Autoimmune Disorders: An Expert Panel Opinion from the American Society for Transplantation and Cellular TherapyOlalekan O Oluwole, Leslie Crofford, Andrew P Jallouk, et al.
Cell Reports|July 18, 2019
Comprehensive Immune Monitoring of Clinical Trials to Advance Human ImmunotherapyFelix J Hartmann, Joel Babdor, Pier Federico Gherardini, et al.
Blood Advances|March 25, 2018
Infusion of donor-derived CD8<sup>+</sup> memory T cells for relapse following allogeneic hematopoietic cell transplantationLori Muffly, Kevin Sheehan, Randall Armstrong, et al.
American Journal of Hematology|April 25, 2024
Management of post-autologous transplant relapse in patients with T-cell lymphomasOlivier Veilleux, Francisco Socola, Sally Arai, et al.
Blood Advances|September 17, 2020
Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphomaWen-Kai Weng, Sally Arai, Andrew Rezvani, et al.
Science Translational Medicine|January 31, 2020
Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawalStephan Busque, John D Scandling, Robert Lowsky, et al.
Bone Marrow Transplantation|August 13, 2020
Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myelomaChristopher Lemieux, Lori S Muffly, Andrew Rezvani, et al.
Blood Advances|September 14, 2021
Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapyAndrew Johnsrud, Juliana Craig, John Baird, et al.
Bone Marrow Transplantation|June 24, 2021
Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myelomaChristopher Lemieux, Lori S Muffly, David J Iberri, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 22, 2020
Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel AgentsChristopher Lemieux, Laura J Johnston, Robert Lowsky, et al.
Transplantation and Cellular Therapy|May 14, 2026
Chimeric Antigen Receptor T-Cell Therapy in Autoimmune Disorders: An Expert Panel Opinion from the American Society for Transplantation and Cellular TherapyOlalekan O Oluwole, Leslie Crofford, Andrew P Jallouk, et al.
Cell Reports|July 18, 2019
Comprehensive Immune Monitoring of Clinical Trials to Advance Human ImmunotherapyFelix J Hartmann, Joel Babdor, Pier Federico Gherardini, et al.
Blood Advances|March 25, 2018
Infusion of donor-derived CD8<sup>+</sup> memory T cells for relapse following allogeneic hematopoietic cell transplantationLori Muffly, Kevin Sheehan, Randall Armstrong, et al.
American Journal of Hematology|April 25, 2024
Management of post-autologous transplant relapse in patients with T-cell lymphomasOlivier Veilleux, Francisco Socola, Sally Arai, et al.
Blood Advances|September 17, 2020
Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphomaWen-Kai Weng, Sally Arai, Andrew Rezvani, et al.
Science Translational Medicine|January 31, 2020
Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawalStephan Busque, John D Scandling, Robert Lowsky, et al.
Bone Marrow Transplantation|August 13, 2020
Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myelomaChristopher Lemieux, Lori S Muffly, Andrew Rezvani, et al.
Blood Advances|September 14, 2021
Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapyAndrew Johnsrud, Juliana Craig, John Baird, et al.
Bone Marrow Transplantation|June 24, 2021
Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myelomaChristopher Lemieux, Lori S Muffly, David J Iberri, et al.
Pageof 5